Distinct effects of IPSU and suvorexant on mouse sleep architecture. - Wikidata - awgldk - TriplyDB

Distinct effects of IPSU and suvorexant on mouse sleep architecture.

Distinct effects of IPSU and suvorexant on mouse sleep architecture.

http://www.wikidata.org/entity/Q42825760

about

Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man.Differential sleep-promoting effects of dual orexin receptor antagonists and GABAA receptor modulators Suvorexant for the treatment of insomnia.Orexin/hypocretin based pharmacotherapies for the treatment of addiction: DORA or SORA?The hypocretin/orexin system: an increasingly important role in neuropsychiatry.Hypocretins, Neural Systems, Physiology, and Psychiatric Disorders.Orexin OX2 Receptor Antagonists as Sleep Aids.Locus Coeruleus and Tuberomammillary Nuclei Ablations Attenuate Hypocretin/Orexin Antagonist-Mediated REM Sleep.Opportunities and perspectives for developing orexin receptor antagonists.Kinetic properties of "dual" orexin receptor antagonists at OX1R and OX2R orexin receptors.Corticothalamic network dysfunction and behavioral deficits in a mouse model of Alzheimer's disease.Lhx6-positive GABA-releasing neurons of the zona incerta promote sleep.Hypocretin underlies the evolution of sleep loss in the Mexican cavefish.Orexin Receptor Antagonists

P2860

Q27347707-AB08892A-0042-437F-B7DB-2A1DA87913B2 Q30423240-116437ED-5345-4505-8A0D-01035285D916 Q34443676-0518E98D-89F2-48A0-801B-35A7C3FDB11F Q38221344-2FCA523F-24A3-4F9E-A5EC-873147D89C1D Q38231949-B19393E6-A731-42FA-B698-2CE5C29AF25C Q38687612-34E94859-C941-437C-925A-37D39EB2CB0B Q39026714-9898187F-3DA8-412A-95B9-9F0ECFDFF1E9 Q39299450-79F843A2-4B50-4748-A839-63810FD9A722 Q40609526-41F134A5-7B32-4DAC-BE41-36C6D5AB0E75 Q41998350-C4E7AA12-401E-4C61-B2D0-E8A0F89FF6EF Q42423885-EF1664F5-127D-4EAE-A011-5B0D91FBD352 Q47635710-43E7513B-1A57-44CC-97DA-6ED53DBC2610 Q48100550-9B78F981-F0CC-405E-8706-0CE7222D8E4D Q59201264-5041A79B-4BB8-4E55-B1EC-B2E65B450719

P2860

Distinct effects of IPSU and suvorexant on mouse sleep architecture.

http://www.wikidata.org/entity/Q42825760

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Distinct effects of IPSU and suvorexant on mouse sleep architecture.

@en

Distinct effects of IPSU and suvorexant on mouse sleep architecture.

@nl

type

label

Distinct effects of IPSU and suvorexant on mouse sleep architecture.

@en

Distinct effects of IPSU and suvorexant on mouse sleep architecture.

@nl

prefLabel

Distinct effects of IPSU and suvorexant on mouse sleep architecture.

@en

Distinct effects of IPSU and suvorexant on mouse sleep architecture.

@nl

P1433

Q42825760-806A580D-3EFA-4344-AEB6-5F5289B4F1D7

P1476

Q42825760-CCBBA44A-8919-44F1-B635-8BFB1935ED4E

P2093

Q42825760-1D0CE10E-C062-46E5-9C85-96221BD3298C

Q42825760-1DF17EC2-3772-441F-A706-602C73E8921B

Q42825760-5142522E-62A0-4735-BA3D-0B8FD38BEB79

Q42825760-80C4F513-7151-4295-A9CB-E146A1EF8A01

Q42825760-8F89A6FA-2980-4994-A519-6566758B8B6D

Q42825760-9768A32B-99C1-43D6-BE1B-007A7F40C61E

Q42825760-DE2BF16E-A775-499B-88B7-E8512A278CB0

Q42825760-EDBA6124-286A-41DE-920A-78C33222D1A8

P2860

Q42825760-080503C5-E4B8-4119-92B9-9E670598CE77

Q42825760-14758EE1-D926-4ABD-BA0D-4CBC211D16F1

Q42825760-14D774F9-20BF-4ED3-96EC-0ABB4924A5F5

Q42825760-15B26F92-8DC6-4F66-9B79-E155B8CB7E60

Q42825760-1A3A21D7-D918-463F-B0FA-2A819E63C5DD

Q42825760-1A444CE7-4849-429A-85BE-051191F6DE3D

Q42825760-214B87DE-7DCC-46F0-AAE4-C80FBCE8D7BD

Q42825760-2B5D4FFB-8F68-4D8B-AAD9-B5EDDBF4857A

Q42825760-3A5E1AF7-8ECC-4495-AD48-E165A997F754

Q42825760-3EEA0531-2655-4D6D-A838-9B9E4E26A2E4

P304

Q42825760-159AD05E-DC87-4306-B208-8872E41FD282

P31

Q42825760-249761D6-A9DC-451D-B921-42B9199BB6EB

P356

Q42825760-2950C62F-3B45-4F01-B851-8C5BE534F955

P478

Q42825760-184DE165-3161-4CCC-A83A-65B6EDB17684

P50

Q42825760-069BD4EE-0267-4B9C-BD5C-CCB9A4E2FE3E

Q42825760-281B5667-7CD0-4612-9F1B-A52441BBEB24

Q42825760-5C4A7FF7-E218-477E-A654-A2AF3C912966

Q42825760-DF1E8433-7DCE-48F9-98D8-1288205F79C9

P577

Q42825760-09D80614-0AAA-429B-B642-3D520045739F

P5875

Q42825760-0E210AF3-8ED9-466E-8F65-899623A3B7BC

P698

Q42825760-1F315A64-61DB-4A4D-BE08-03E3D74F7285

P921

Q42825760-9CC16F19-AD07-4A4D-AA81-DCCD7F64C794

P932

Q42825760-5EB4C5F4-22DC-48BC-898D-0EE294BA3628

P356

FNINS.2013.00235

P1433

Frontiers in Neuroscience

P1476

Distinct effects of IPSU and suvorexant on mouse sleep architecture.

@en

P2093

Claudia Betschart

http://www.w3.org/2001/XMLSchema#string

Dirk Behnke

http://www.w3.org/2001/XMLSchema#string

Eric Legangneux

http://www.w3.org/2001/XMLSchema#string

Grit Laue

http://www.w3.org/2001/XMLSchema#string

Samuel Hintermann

http://www.w3.org/2001/XMLSchema#string

Silvio Ofner

http://www.w3.org/2001/XMLSchema#string

Simona Cotesta

http://www.w3.org/2001/XMLSchema#string

Thomas Dürst

http://www.w3.org/2001/XMLSchema#string

P2860

Dual hypocretin receptor antagonism is more effective for sleep promotion than antagonism of either receptor alone

Cholinergic modulation of narcoleptic attacks in double orexin receptor knockout mice

The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene

A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains

Phase I studies on the safety, tolerability, pharmacokinetics and pharmacodynamics of SB-649868, a novel dual orexin receptor antagonist

Differential effects of a dual orexin receptor antagonist (SB-649868) and zolpidem on sleep initiation and consolidation, SWS, REM sleep, and EEG power spectra in a model of situational insomnia

The orexin antagonist SB-649868 promotes and maintains sleep in men with primary insomnia

Evidence implicating a role for orexin-1 receptor modulation of paradoxical sleep in the rat

Beta2-containing nicotinic receptors contribute to the organization of sleep and regulate putative micro-arousals in mice

Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation

P304

235

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FNINS.2013.00235

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Christine E Gee

Laura H Jacobson

P577

2013-12-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259462961

http://www.w3.org/2001/XMLSchema#string

P698

24368893

http://www.w3.org/2001/XMLSchema#string

P921

P932

3857892

http://www.w3.org/2001/XMLSchema#string